Type 2 Diabetes in the U.S. Market: 2014 to 2024

Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the U.S. Market: 2014 to 2024" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Type 2 Diabetes pipeline products, Type 2 Diabetes epidemiology, Type 2 Diabetes market valuations and forecast, Type 2 Diabetes drugs sales and competitive landscape in the US.

The research is classified into seven sections- Type 2 Diabetes treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

• Type 2 Diabetes pipeline: Find out the products in clinical trials for the treatment of Type 2 Diabetes by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
• Type 2 Diabetes epidemiology: Find out the number of patients diagnosed (prevalence) with Type 2 Diabetes in the US
• Type 2 Diabetes drugs: Identify key products marketed and prescribed for Type 2 Diabetes in the US, including trade name, molecule name, and company
• Type 2 Diabetes drugs sales: Find out the sales revenues of Type 2 Diabetes drugs in the US
• Type 2 Diabetes market valuations: Find out the market size for Type 2 Diabetes drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
• Type 2 Diabetes drugs market share: Find out the market shares for key Type 2 Diabetes drugs in the US

Benefits of this Research

• Support monitoring and reporting national Type 2 Diabetes market analysis and sales trends
• Track competitor drugs sales and market share in the US Type 2 Diabetes market
• Track competitive developments in Type 2 Diabetes market and present key issues and learnings
• Synthesize insights for Type 2 Diabetes market and products to drive business performance
• Answer key business questions about the Type 2 Diabetes market
• Evaluate commercial market opportunity assessment, positioning, and segmentation for Type 2 Diabetes products
• Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Type 2 Diabetes Treatments
2) Type 2 Diabetes Pipeline
3) US Type 2 Diabetes Epidemiology
4) Marketed Drugs for Type 2 Diabetes in US
5) US Type 2 Diabetes Market Size and Forecast
6) US Type 2 Diabetes Products Sales and Forecast
7) US Type 2 Diabetes Market Competitive Landscape
8) Methodology

List of Tables
1. Type 2 Diabetes Phase 3 Clinical Trials, 2019
2. Type 2 Diabetes Phase 2 Clinical Trials, 2019
3. Type 2 Diabetes Phase 1 Clinical Trials, 2019
4. Type 2 Diabetes Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Type 2 Diabetes, US, 2018
6. Type 2 Diabetes Market Size and Forecast ($), US, 2014 - 2024
7. Type 2 Diabetes Product Sales ($), US, 2014 - 2024

List of Figures
1. Type 2 Diabetes Epidemiology, US, 2014 - 2024
2. Type 2 Diabetes Market Size and Forecast ($), US, 2014 - 2024
3. Type 2 Diabetes Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/3mma9p

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs, Diabetes Drugs